Stock Events

Stock Events

Search...

Summit Therapeutics (SMMT) Q1 2026 Earnings

23FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.76

-0.53

-0.3

-0.08

Details

Expected EPS

-0.077448

Actual EPS

-0.29

Surprise EPS

-0.21

Surprise Percent

+274.44%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.29 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.